The Top Belly Fat Reduction Peptides to Lose 5-7lbs | Dr. William Seeds

Dr. Seeds emphasizes that MOTS-c is a stress response peptide: when a cell is under stress, the mitochondria send MOTS-c to the nucleus to initiate protective efficiencies. He uses it in patients who have already improved their metabolic flexibility with GLP-1s, as a 'next phase' to fine-tune. The goal is not just fat loss but making the cell more efficient at utilizing all substrates. He notes that even healthy people may have undiagnosed insulin sensitivity issues, and MOTS-c can level the playing field, especially as we age. Thomas DeLauer adds that athletes report better fuel utilization and glycogen storage, and that MOTS-c could accelerate the fat adaptation process that low-carb dieters work hard to achieve.

Dr. Seeds describes SS-31 as a structural peptide, contrasting it with the more metabolic MOTS-c. He explains that cardiolipin is uniquely susceptible to oxidative damage, and when it's destroyed, the mitochondria lose their power. SS-31 not only protects cardiolipin but also has intrinsic antioxidant properties and supports stem cell health. He believes there is always a role for SS-31 in oxidative stress because mitochondria are invariably affected. He personally rotates mitochondrial peptides to achieve different levels of efficiency in patients.

Thomas DeLauer asks about peptides that affect uncoupling proteins. Dr. Seeds responds that GLP-1s are major players in this area, improving UCP1 and UCP2. He explains that uncoupling is a natural way to dissipate excess energy as heat, preventing the proton motive force from becoming too high. This thermogenic process is one reason GLP-1s are effective for weight loss, but even at low doses, they can provide these benefits without significant weight reduction. He emphasizes that GLP-1s also have benefits in the brain, bone, and muscle, making them useful beyond weight management. This protocol can serve as a foundation before introducing mitochondrial peptides like MOTS-c.

Dr. Seeds explains that he views MOTS-c as working on metabolism and SS-31 on structure. He believes that rotating them allows patients to reach different levels of efficiency. He mentions that in any oxidative stress issue, there is a place for SS-31 because mitochondria are always affected. This rotation strategy is part of his clinical approach to peptide therapy.

Dr. Seeds explains that MOTS-c is a mitochondrial-derived peptide that acts as a stress response when the cell is in trouble. It is a transcription factor that goes to the nucleus to improve cell efficiencies, protein folding, and metabolic flexibility. He notes that even fit individuals may have subtle insulin sensitivity issues that can be improved. Thomas DeLauer adds that athletes who are tuned into their bodies report feeling better fuel utilization and glycogen storage when using MOTS-c. Dr. Seeds agrees, pointing to the AKT mechanism that enhances glycogen storage and the fact that many athletes overtrain, creating inefficiencies that MOTS-c can address. He also mentions that centenarians naturally produce more MOTS-c, suggesting a longevity link. The peptide increases AICAR (which activates AMPK) and NAD simultaneously, improving glucose uptake without over-revving oxidative phosphorylation, and it also promotes autophagy and beta-oxidation of fat indirectly by making the cell more efficient.

Dr. Seeds explains that cardiolipin is a phospholipid in the inner mitochondrial membrane that is essential for the cristae where electron transport and oxidative phosphorylation occur. Under high oxidative stress, cardiolipin gets destroyed, leading to loss of proton motive force, reduced ATP and NAD production, and impaired cell signaling. SS-31 helps protect cardiolipin, thus maintaining the mitochondria's power. Additionally, SS-31 has antioxidant properties and helps keep stem cells in a quiescent, healthy metabolic state, ready to activate when needed. Dr. Seeds views SS-31 as a 'higher level' peptide that can be rotated with MOTS-c to address both structure and metabolism. He believes there is always a place for SS-31 in any oxidative stress issue because the mitochondria are always affected.

Thomas DeLauer asks if there is literature on GLP-1s causing beiging of white fat. Dr. Seeds confirms that in rodent studies and emerging human data, GLP-1s can convert white adipose tissue to brown adipose tissue, though not in large amounts. This conversion increases thermogenic capacity, allowing more energy to be dissipated as heat. He ties this to the uncoupling protein system, where GLP-1s upregulate UCP1 and UCP2, which are key for thermogenesis. This effect is part of why GLP-1s are so effective for weight loss beyond just calorie reduction. He also mentions that different iterations of GLP-1s (next-gen) may have more pronounced beiging effects.